Skip to main content

Advertisement

Table 1 Demographic and histopathologic information of the bladder cancer patients and controls providing urinary samples utilized for DNA profiling using oligonucleotide array-CGH

From: Identification of prefoldin amplification (1q23.3-q24.1) in bladder cancer using comparative genomic hybridization (CGH) arrays of urinary DNA

Bladder Cancer Patients
ID Gendera Age Stage Grade
105 HG M 65 pTA G1
125 HG F 51 pTA G1
130 HG M 54 pTA G1
136 HG M 58 pTA G1
138 HG F 70 pTA G3
75 HS M 75 pT1 G2
123 HG M 78 pT1 G2
131 HG M 81 pT1 G2
141 HG M 72 pT1 G3
127 HG M 79 pT2 G3
132 HG M 74 pT2 G3
139 HG M 69 pT2 G3
129 HG M 66 pT2 G3
100 HG M 78 pT4 G3
Controls
ID Gender a Age Pool Status
DNA 19/10 F 30 1 Healthy donor
76HS M 83 1 No evidence of disease
79HS F 73 1 & 2 Cystitis
111HG M 55 1 No evidence of disease
116HG F 61 2 Healthy donor
118HG M 61 1 & 2 No evidence of disease
135HG M 51 2 Healthy donor
143HG F 71 2 Healthy donor
  1. aM, Male; F, Female.